Akara Raises £4.1M to Accelerate Hospital AI Adoption

The big picture: Irish healthcare technology company Akara has raised £4.1M ($5.5M) in venture funding, bringing its total funding to £9.4M ($12.3M). This latest investment aims to accelerate the adoption of its AI technology in hospitals, which combines privacy-preserving sensors with robotics and AI tools to reduce administrative work, coordinate services, and treat more patients.

Why it matters:

• Staff Burden: Hospitals face immense pressure from growing demand for care, compounded by staff shortages and rising costs, with an estimated 40% of nursing time spent on routine administrative and coordination tasks.
• Operational Efficiency: Akara’s technology aims to free up valuable staff time by automating fragmented processes like manual data entry, scheduling, and repeated checks, allowing healthcare professionals to focus more on patient care.
• Scalable Solution: The company’s approach prioritizes privacy, straightforward deployment, and affordability, making its AI agents a sustainable and accessible solution for hospitals seeking to enhance operational capacity.

How it works:

• Privacy-Preserving Sensors: Akara’s proprietary wall-mounted sensors use thermal data to understand how clinical spaces are used without capturing detailed visual images of patients or staff, ensuring privacy protection.
• Edge AI Processing: The AI necessary to interpret thermal data runs directly on the device (edge AI), allowing key events to be detected locally, limiting the transmission of sensitive information, and reducing reliance on additional computing infrastructure.
• AI Agents & Coordination: The software functions as an ‘air traffic controller,’ detecting critical events and notifying staff when needed. AI agents enable staff to query data in natural language and generate reports, streamlining operational improvements.

The catch: The healthcare sector is notoriously slow to adopt new technologies due to complex integration requirements, stringent regulatory hurdles, and high upfront costs. While Akara’s focus on privacy and affordability addresses key barriers, widespread adoption will depend on demonstrating clear return on investment and seamless integration into existing hospital workflows without adding significant burden to already stretched IT departments and staff training. Competition from established healthcare IT providers and other AI solutions also presents a challenge.

Key Facts

• Company: Akara
• Amount: £4.1M
• Investors: Locke Health (lead), VTC Ventures, EIC Fund, CommonKind, NovaVector Holdings, ACT, Atlantic Bridge, Enterprise Ireland, strategic angel investors
• Founder: Dr Conor McGinn
• Sector: Hospital AI Operations
• Headquarters: Dublin, Ireland